|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/01/22 Glucose Health, Inc. S-1 5/31/22 63:17M Discount Edgar/FA |
Document/Exhibit Description Pages Size
1: S-1 Registration Statement (General Form) HTML 1.15M
2: EX-2.1 Plan and Agreement of Merger HTML 30K
3: EX-2.2 Certificate of Merger HTML 56K
4: EX-3.1 Articles of Conversion HTML 16K
5: EX-3.2 Certificate of Conversion HTML 27K
6: EX-3.3 Amended and Restated Certificate of Incorporation HTML 52K
7: EX-3.4 Amended and Restated Bylaws HTML 63K
8: EX-3.5 Certificate of Correction HTML 19K
9: EX-10.2 Series B Preferred Stock Purchase Agreemen HTML 81K
10: EX-10.3 Series C Preferred Stock Purchase Agreement HTML 77K
11: EX-10.4 Series D Preferred Stock Purchase Agreement HTML 82K
12: EX-10.5 Series E Preferred Stock Purchase Agreement HTML 100K
13: EX-10.6 Convertible Promissory Note HTML 34K
14: EX-10.7 Services Agreement HTML 25K
15: EX-10.8 Consulting Agreement HTML 41K
16: EX-23.1 Consent of Expert or Counsel HTML 16K
19: EX-FILING FEES Filling Fee Table HTML 35K
17: EX-99.4 Consent HTML 17K
18: EX-99.5 Consent HTML 17K
25: R1 Cover HTML 47K
26: R2 Balance Sheets HTML 110K
27: R3 Balance Sheets (Parenthetical) HTML 53K
28: R4 Statements of Operations HTML 97K
29: R5 Statements of Shareholders' Equity HTML 68K
30: R6 Statements of Cash Flows HTML 95K
31: R7 Organization and Basis of Presentation HTML 30K
32: R8 Summary of Significant Accounting Policies HTML 82K
33: R9 Stockholders Equity HTML 85K
34: R10 Notes Payable HTML 32K
35: R11 Federal Income Tax HTML 51K
36: R12 Commitments Contingencies HTML 22K
37: R13 REVENUE CONCENTRATION and ACCOUNTS RECEIVABLE HTML 20K
38: R14 Recovery of Retailer Chargebacks HTML 20K
39: R15 Related Party Transactions HTML 22K
40: R16 Subsequent Events HTML 24K
41: R17 Summary of Significant Accounting Policies HTML 110K
(Policies)
42: R18 Summary of Significant Accounting Policies HTML 31K
(Tables)
43: R19 Stockholders Equity (Tables) HTML 57K
44: R20 Federal Income Tax (Tables) HTML 44K
45: R21 Organization and Basis of Presentation (Details HTML 48K
Narrative)
46: R22 Summary of Significant Accounting Policies HTML 24K
(Details)
47: R23 Summary of Significant Accounting Policies HTML 38K
(Details Narrative)
48: R24 Stockholders Deficit (Details) HTML 42K
49: R25 Stockholders Deficit (Details 1) HTML 32K
50: R26 Stockholders Deficit (Details Narrative) HTML 75K
51: R27 Notes Payable (Details Narrative) HTML 70K
52: R28 Federal Income Tax (Details) HTML 25K
53: R29 Federal Income Tax (Details 1) HTML 28K
54: R30 Federal Income Tax (Details Narrative) HTML 24K
55: R31 REVENUE CONCENTRATION and ACCOUNTS RECEIVABLE HTML 27K
(Details Narrative)
56: R32 Recovery of Retailer Chargebacks (Details HTML 19K
Narrative)
57: R33 Related Party Transactions (Details Narrative) HTML 23K
58: R34 Subsequent Events (Details Narrative) HTML 54K
61: XML IDEA XML File -- Filing Summary XML 90K
59: XML XBRL Instance -- gluc_s1_htm XML 949K
60: EXCEL IDEA Workbook of Financial Reports XLSX 58K
22: EX-101.CAL XBRL Calculations -- gluc-20220331_cal XML 105K
24: EX-101.DEF XBRL Definitions -- gluc-20220331_def XML 337K
21: EX-101.LAB XBRL Labels -- gluc-20220331_lab XML 553K
23: EX-101.PRE XBRL Presentations -- gluc-20220331_pre XML 468K
20: EX-101.SCH XBRL Schema -- gluc-20220331 XSD 116K
62: JSON XBRL Instance as JSON Data -- MetaLinks 215± 282K
63: ZIP XBRL Zipped Folder -- 0001477932-22-004038-xbrl Zip 605K
EXHIBIT 99.4
CONSENT OF DIRECTOR NOMINEE
In connection with the filing by Glucose Health, Inc. (the “Company”) of a Registration Statement on Form S-1 (together with any amendments or supplements thereto, the “Registration Statement”) with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), the undersigned hereby consents, as required by Rule 438 under the Securities Act, to being named in the Registration Statement as a Director Nominee.
|
By: | /s/ Robert Sipper |
|
|
| Name: |
|
|
| This ‘S-1’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed as of: | 6/1/22 | None on these Dates | ||
| Filed on: | 5/31/22 | |||
| 5/18/22 | ||||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/09/23 Glucose Health, Inc. S-1/A 59:7M Discount Edgar/FA 9/06/22 Glucose Health, Inc. S-1/A 9/02/22 49:5.9M Discount Edgar/FA 8/05/22 Glucose Health, Inc. S-1/A 49:5.7M Discount Edgar/FA |